- Investing Ideas
- Hong Kong Pharmaceuticals & Biotech Profitable Climbers
Hong Kong Pharmaceuticals & Biotech Profitable Climbers
Results
11
11 companies
WuXi XDC Cayman
Market Cap: HK$71.8b
An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.
2268
HK$57.10
7D
1.5%
1Y
36.3%
Biocytogen Pharmaceuticals (Beijing)
Market Cap: HK$38.5b
A biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People’s Republic of China, the United States, and internationally.
2315
HK$55.35
7D
0.6%
1Y
266.1%
RemeGen
Market Cap: HK$65.3b
A biopharmaceutical company, discovers, develops, produces, and commercializes biological drugs for the treatment of autoimmune, oncology, and ophthalmic diseases in Mainland China and the United States.
9995
HK$91.65
7D
-6.5%
1Y
354.8%
CanSino Biologics
Market Cap: HK$13.0b
Develops, manufactures, and commercializes vaccines in the People’s Republic of China.
6185
HK$31.88
7D
-9.4%
1Y
-5.1%
JBM (Healthcare)
Market Cap: HK$2.2b
An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.
2161
HK$2.66
7D
-2.2%
1Y
47.0%
Consun Pharmaceutical Group
Market Cap: HK$13.6b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$16.19
7D
-6.5%
1Y
84.2%
Innovent Biologics
Market Cap: HK$143.2b
A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, and internationally.
1801
HK$82.55
7D
-2.7%
1Y
111.4%
Beijing Tong Ren Tang Chinese Medicine
Market Cap: HK$6.6b
Engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals.
3613
HK$7.89
7D
-7.8%
1Y
-9.3%
Luye Pharma Group
Market Cap: HK$9.4b
Develops, produces, markets, and sells pharmaceutical products in the People’s Republic of China, the United States, Europe, and internationally.
2186
HK$2.36
7D
-6.3%
1Y
2.6%
Simcere Pharmaceutical Group
Market Cap: HK$29.3b
An investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products to distributors, pharmacy chains, and other pharmaceutical manufacturers in China.
2096
HK$11.33
7D
-7.0%
1Y
49.3%
China Medical System Holdings
Market Cap: HK$32.1b
An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.
867
HK$13.27
7D
-3.3%
1Y
76.9%